Today news
About the same in other media
EU grants fast-track assessment to AstraZeneca’s COVID-19 prevention drug
Reading now: 278
financialexpress.comAstraZeneca on Monday announced that the EU drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, Sipavibart, under an accelerated assessment.
According to the company’s press statement, the submission was based on positive data from a late-stage trial that showed the drug helped reduce the incidence of COVID-19 in immunocompromised patients.
(With inputs from Reuters)
Read more on financialexpress.comAbout this in other media
Pharma companies against plan to bring nutraceuticals under drug regulator economictimes.indiatimes.com /5 months ago
Circle Granted License for USDC and EURC Issuance Under Europe’s MiCA Framework cryptonews.com /5 months ago
India's EV plans to get a policy boost as govt may fast-track 3 big-ticket schemes economictimes.indiatimes.com /5 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
